Correction to: Pre-clinical evaluation of Minnelide as a therapy for acute myeloid leukemia.

Following publication of the original article [1], the authors found an error in Figure 3. The middle panel of Figure 3a was inadvertently duplicated.

Correction to: J Transl Med (2019) 17:163 10.1186/s12967-019-1901-8

Following publication of the original article [1], the authors found an error in Fig. 3. The middle panel of Fig. 3a was inadvertently duplicated.

Fig. 3

a Treatment with triptolide resulted in a decrease in colony forming ability of AML cell lines THP-1 and KG1a as measured by a methylcellulose based colony forming assay. Treatment with triptolide also caused a decrease in surface markers of commonly expressed stem cell markers in AML cell lines THP-1 (b) and KG1a (c). n = 3, *p < 0.05 when compared to untreated cells, data shows mean ± SD

In this Correction the incorrect and corrected version of Fig. 3 are shown.

Originally Fig. 3 was published as:

The corrected version of Fig. 3:

Fig. 3

a Treatment with triptolide resulted in a decrease in colony forming ability of AML cell lines THP-1 and KG1a as measured by a methylcellulose based colony forming assay. Treatment with triptolide also caused a decrease in surface markers of commonly expressed stem cell markers in AML cell lines THP-1 (b) and KG1a (c). n = 3, *p < 0.05 when compared to untreated cells, data shows mean ± SD